
Bistrofam 40mg Injection
Marketer
Riqfame Critical Care Private Limited
Salt Composition
Pantoprazole (40mg)
Overview Bistrofam 40mg Injection
AcidGard 40mg Injection lowers stomach acid production. It treats acid-related conditions affecting the stomach and intestines, such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome, offering symptom relief and promoting healing. AcidGard 40mg Injection also prevents stress ulcers in critically ill patients and is administered pre-anesthesia to reduce aspiration risks. A proton pump inhibitor (PPI), it's intravenously administered by a healthcare professional only when deemed necessary by your physician instead of oral medication. Dosage varies based on individual needs and response. Your doctor determines treatment duration; continue as prescribed even with rapid symptom improvement. Smaller, more frequent meals and avoidance of caffeine, spicy, and fatty foods enhance treatment efficacy. Common side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). While usually mild, persistent or bothersome symptoms warrant medical attention. Prolonged use increases side effect risk; usage exceeding one year may elevate bone fracture risk, particularly at higher doses. Discuss bone loss (osteoporosis) prevention strategies, such as calcium and vitamin D supplements, with your doctor. AcidGard 40mg Injection is unsuitable for some individuals. Inform your doctor of severe liver disease, HIV medication use, prior allergic reactions to similar medications, or existing osteoporosis before use. Pregnant or breastfeeding individuals should seek medical advice. Alcohol consumption should be avoided due to its acid-stimulating effect. Refrain from operating machinery if dizziness or drowsiness occurs.
Primary Ingredients of Bistrofam 40mg Injection
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Bistrofam 40mg Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Bistrofam 40mg Injection:
The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Bistrofam 40mg Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Bistrofam 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Bistrofam 40mg Injection works:
Gastric acid production is diminished by the proton pump inhibitor Bistrofam 40mg Injection, thereby alleviating symptoms of heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol and Bistrofam 40mg Injection should not be used together.
PregnancyCONSULT YOUR DOCTOR
Administering Bistrofam 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Bistrofam 40mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Bistrofam 40mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Bistrofam 40mg Injection poses no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverCAUTION
For patients with severe hepatic impairment, administration of Bistrofam 40mg Injection requires careful monitoring. Dosage modification of Bistrofam 40mg Injection may be necessary. Physician consultation is advised.
What if you forget to take Bistrofam 40mg Injection :
Omit a scheduled Bistrofam 40mg Injection? Seek your physician's advice.
Facts to Know About Bistrofam 40mg Injection
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Actions | Gastric acid suppressants |
